Cargando…
Imidazo[1,2-a]quinoxalines Derivatives Grafted with Amino Acids: Synthesis and Evaluation on A375 Melanoma Cells
Imiqualines (imidazoquinoxaline derivatives) are anticancer compounds with high cytotoxic activities on melanoma cell lines. The first generation of imiqualines, with two lead compounds (EAPB0203 and EAPB0503), shows remarkable in vitro (IC(50) = 1 570 nM and IC(50) = 200 nM, respectively, on the A3...
Autores principales: | Chouchou, Adrien, Patinote, Cindy, Cuq, Pierre, Bonnet, Pierre-Antoine, Deleuze-Masquéfa, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278480/ https://www.ncbi.nlm.nih.gov/pubmed/30445763 http://dx.doi.org/10.3390/molecules23112987 |
Ejemplares similares
-
[1,2,4]triazolo[4,3-a]quinoxaline as Novel Scaffold in the Imiqualines Family: Candidates with Cytotoxic Activities on Melanoma Cell Lines
por: Patinote, Cindy, et al.
Publicado: (2023) -
Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503
por: Chouchou, Adrien, et al.
Publicado: (2017) -
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
por: Patinote, Cindy, et al.
Publicado: (2020) -
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling
por: Hamie, Maguy, et al.
Publicado: (2021) -
Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
por: Kumar, Manvendra, et al.
Publicado: (2021)